marquee_healthcare_deals

Business Health

Piramal Enterprises acquires baby care brand Little’s

Date posted: Saturday 7 November 2015

Piramal Enterprises Ltd has entered the baby care segment by acquiring a 100% stake in Little’s India, the country’s oldest baby care products brand, for an undisclosed amount. This acquisition will add eight categories to Piramal Enterprises’ consumer product division.

Little’s baby care range includes feeding, grooming, bath, bedtime, clothing, travel and playtime accessories.

(Live Mint)



YourDOST raises Rs 2.5 cr through angel funding

Date posted: Saturday 7 November 2015

Online counselling provider YourDOST has raised an amount of $400,000 (Rs 2.6 crore) in seed round of funding from a group of angel investors. The investors who have participated in the round are redBus Co-Founder Phanindra Sama, Smartur founder Neeraj Jawalkar, TaxiForSure Co-Founder Aprameya Radhakrishna, Capillary Technologies founder Aneesh Reddy. Other investors who have also taken part in the funding were Sanjay Anandaram, partner at Seedfund; Pavan Ongole, former Director at SoftBank; and nuVentures Co-Founder Venk Krishnan. The raised funds will be used for marketing and expansion plans.

Founded in 2014, the startup offers online counselling to people who are in distress. The startup provides expert counselling to its users and also keeps their identity anonymous.

(I am Wire)



Rothschild mandated for KIMS’ $400m share sale

Date posted: Saturday 7 November 2015

Global buyout investors are in the fray for a $400-million majority share acquisition in KIMS Group of Hospitals, a Kerala-based healthcare network with footprint in southern India and he Middle East. KIMS and its main shareholders Ascent Capital and OrbiMed have appointed investment bank NM Rothschild for a large fund-raise, drawing the nterest of private equity giants including Carlyle, Apax Partners, Baring Asia, Bain Capital and TPG. The deal will see Ascent and OrbiMed selling their controlling interest for about $200 million and the company raising an equal amount of fresh capital for expansion and inorganic growth.

KIMS Group operates a chain of speciality hospitals and medical centres across Kerala, Tamil Nadu and the Middle East -Dubai, Bahrain, Oman, Qatar and Saudi Arabia -with about 1,700 beds.

(Times of India)



Ipca Laboratories makes open offer to buy shares of Krebs Bio

Date posted: Saturday 7 November 2015

Ipca Laboratories Ltd has made an open offer to the shareholders of Hyderabad-based Krebs Biochemicals and Industries Ltd (KBIL). Mumbai-based formulates and API maker Ipca will acquire about 35.73 lakh shares of Krebs (of the face value of Rs. 10 each) at a price of Rs. 54 per share.

Established in 1991, KBIL undertakes contract manufacturing. It has expertise and infrastructure in the areas of chemical synthesis, fermentation and enzymatic technologies.

(The Hindu)

 



Government caps prices of new drugs to treat diabetes, hypertension

Date posted: Saturday 7 November 2015

New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight. The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs Price Control Order (DPCO), 2013, and has fixed their maximum retail price at the average of MRP of all medicines available in that particular therapeutic segment with at least 1% market share.

The NPPA move is expected to provide consumers with more treatment options which are also cheaper for critical diseases like diabetes and hypertension. On the other hand, it is likely to keep a check on companies trying to launch price controlled formulations under new and different brands after minor changes in the composition or dosage.

(Economic Times)





Subscribe to Business Health – weekly newsletter
* = required field